Coproporphyria, Hereditary: Clinical Trials

1 trial for Coproporphyria, Hereditary, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Coproporphyria, Hereditary: new trials by email Literature Review of Coproporphyria, Hereditary trials Research Report on Coproporphyria, Hereditary

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Interaction Between Givosiran and a 5-probe Drug Cocktail in Patients With Acute Intermittent Porphyria (AIP)
Givosiran, 5-probe cocktail - Acute Intermittent Porphyria (AIP), Acute Hepatic Porphyria (AHP)
Phase 1CompletedAlnylam Pharmaceuticals102018-04-262019-03-12

Narrower conditions

Porphyria, Acute Intermittent (1)  ·  Porphyrias (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Liver Diseases (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Porphyrias, Hepatic (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Genetic (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

givosiran (1)

Sponsors

Alnylam Pharmaceuticals (1)

Countries

Sweden (1)

Top investigators

Nader Najafian, MD (1)